SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

Now, the Lundquist Institute (TLI) and Vitalex Biosciences announce that they will move forward in the development of the second-generation fungal vaccine candidate known as VXV‑01—up to and including ...

The hydrogel preservation technology maintains cell viability for days at room temperature, removing cold-chain constraints.

A new method uses the auxin-inducible degron (AID) system to tune protein levels with precision in living C. elegans.

Investigations suggest V2P may be efficiently applied for the automated identification of causal variants in simulated and actual patient sequencing data across phenotypes.

Pairing a drug that targets the PRDM9 gene with a cholesterol-lowering agent shrank brain tumors and improved survival in mice.

Results open the door to therapies based on chronobiology, the branch of biology that studies how living organisms structure their physiological processes in time.

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

High-quality genome assemblies and CRISPR editing were used in goldenberries to generate more compact and manageable plants.

Researchers at Concordia University say they are now able to bring promising innovations from concept to pilot under one roof.

Organoids with both intestinal and colonic regions are able to better represent the human GI tract with Ebola and Marburg infections.

STEM-engineered CAR T cells performed as well as or better against cancer cells than did FDA-approved CAR T cells and kept their cancer-fighting abilities for longer.